|
Name |
2,4-Dimethylbenzaldehyde
|
Molecular Formula | C9H10O | |
IUPAC Name* |
2,4-dimethylbenzaldehyde
|
|
SMILES |
CC1=CC(=C(C=C1)C=O)C
|
|
InChI |
InChI=1S/C9H10O/c1-7-3-4-9(6-10)8(2)5-7/h3-6H,1-2H3
|
|
InChIKey |
GISVICWQYMUPJF-UHFFFAOYSA-N
|
|
Synonyms |
2,4-Dimethylbenzaldehyde; 15764-16-6; Benzaldehyde, 2,4-dimethyl-; 2,4-dimethyl benzaldehyde; 2,4-Xylylaldehyde; 1-Formyl-2,4-dimethylbenzene; 2,4-Dimethylbenzenecarboxaldehyde; 2,4-dimethyl-benzaldehyde; FEMA No. 3427; m-Xylene-4-carboxaldehyde; I06YU18H4A; MFCD00003340; UNII-I06YU18H4A; m-Xylylaldehyde; 2,4-TRIMETHYL BENZALDEHYDE; EINECS 239-856-7; 2,3-Dimethybenzaldehyde; SCHEMBL95501; FEMA 3427; DTXSID60166297; CHEBI:178624; 2,4-Dimethylbenzaldehyde, >=90%; AMY37066; ZINC1850617; NSC804813; STL185603; AKOS000120288; AC-3324; CS-W011068; NSC-804813; 2,4-DIMETHYLBENZALDEHYDE [FHFI]; DS-15791; SY004505; DB-023755; D2392; FT-0637272; FT-0652948; EN300-20657; 2,4-Dimethylbenzaldehyde, technical grade, 90%; A809861; W-108000; Q27280189; 2,4-Dimethylbenzaldehyde, Vetec(TM) reagent grade, 95%; Z104479608
|
|
CAS | 15764-16-6 | |
PubChem CID | 61814 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 134.17 | ALogp: | 2.5 |
HBD: | 0 | HBA: | 1 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 17.1 | Aromatic Rings: | 1 |
Heavy Atoms: | 10 | QED Weighted: | 0.54 |
Caco-2 Permeability: | -4.361 | MDCK Permeability: | 0.00002460 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.028 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.003 |
30% Bioavailability (F30%): | 0.003 |
Blood-Brain-Barrier Penetration (BBB): | 0.988 | Plasma Protein Binding (PPB): | 84.81% |
Volume Distribution (VD): | 1.123 | Fu: | 14.99% |
CYP1A2-inhibitor: | 0.928 | CYP1A2-substrate: | 0.925 |
CYP2C19-inhibitor: | 0.607 | CYP2C19-substrate: | 0.781 |
CYP2C9-inhibitor: | 0.132 | CYP2C9-substrate: | 0.67 |
CYP2D6-inhibitor: | 0.018 | CYP2D6-substrate: | 0.863 |
CYP3A4-inhibitor: | 0.05 | CYP3A4-substrate: | 0.366 |
Clearance (CL): | 5.273 | Half-life (T1/2): | 0.595 |
hERG Blockers: | 0.028 | Human Hepatotoxicity (H-HT): | 0.019 |
Drug-inuced Liver Injury (DILI): | 0.097 | AMES Toxicity: | 0.172 |
Rat Oral Acute Toxicity: | 0.029 | Maximum Recommended Daily Dose: | 0.436 |
Skin Sensitization: | 0.309 | Carcinogencity: | 0.386 |
Eye Corrosion: | 0.986 | Eye Irritation: | 0.997 |
Respiratory Toxicity: | 0.969 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000552 | 0.742 | D06GIP | 0.366 | ||||
ENC000180 | 0.545 | D0E9CD | 0.326 | ||||
ENC001334 | 0.459 | D05VIX | 0.316 | ||||
ENC000498 | 0.459 | D01PJR | 0.280 | ||||
ENC000414 | 0.444 | D0X0RI | 0.265 | ||||
ENC001744 | 0.442 | D01PZD | 0.258 | ||||
ENC000239 | 0.400 | D03WEX | 0.257 | ||||
ENC000734 | 0.385 | D02WCI | 0.241 | ||||
ENC000172 | 0.385 | D0X4RN | 0.237 | ||||
ENC000696 | 0.385 | D0T3NY | 0.236 |